BigHat Biosciences
Back to full portfolio
BigHat Biosciences is a clinical-stage biotechnology company. It designs and engineers therapeutic antibodies, from antibody-drug conjugates to T-cell engagers across oncology and immunology, on a platform where machine learning and an automated wet lab run as one loop, with each round of lab data training the next round of designs. That loop yields candidates engineered to balance binding, stability, and manufacturability together.
FOUNDER(S)
Peyton Greenside
LEADERSHIP
Peyton Greenside
BigHat Biosciences is a clinical-stage biotechnology company. It designs and engineers therapeutic antibodies, from antibody-drug conjugates to T-cell engagers across oncology and immunology, on a platform where machine learning and an automated wet lab run as one loop, with each round of lab data training the next round of designs. That loop yields candidates engineered to balance binding, stability, and manufacturability together.
